BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26657080)

  • 1. The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.
    Giguère SS; Guise AJ; Jean Beltran PM; Joshi PM; Greco TM; Quach OL; Kong J; Cristea IM
    Mol Cell Proteomics; 2016 Mar; 15(3):791-809. PubMed ID: 26657080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC3 is negatively regulated by the nuclear protein DBC1.
    Chini CC; Escande C; Nin V; Chini EN
    J Biol Chem; 2010 Dec; 285(52):40830-7. PubMed ID: 21030595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Functional Proteomics Perspective of DBC1 as a Regulator of Transcription.
    Joshi P; Quach OL; Giguere SS; Cristea IM
    J Proteomics Bioinform; 2013 Apr; Suppl 2():. PubMed ID: 24273392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.
    Yu EJ; Kim SH; Heo K; Ou CY; Stallcup MR; Kim JH
    Nucleic Acids Res; 2011 Sep; 39(16):6932-43. PubMed ID: 21596782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
    Pangon L; Mladenova D; Watkins L; Van Kralingen C; Currey N; Al-Sohaily S; Lecine P; Borg JP; Kohonen-Corish MR
    Int J Cancer; 2015 Jan; 136(1):55-64. PubMed ID: 24824780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1.
    Zhang H; Xu Y; Filipovic A; Lit LC; Koo CY; Stebbing J; Giamas G
    Br J Cancer; 2013 Nov; 109(10):2675-84. PubMed ID: 24129246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.
    Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C
    Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes.
    Basu S; Barad M; Yadav D; Nandy A; Mukherjee B; Sarkar J; Chakrabarti P; Mukhopadhyay S; Biswas D
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6509-6520. PubMed ID: 32152128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.
    Yu EJ; Kim SH; Kim HJ; Heo K; Ou CY; Stallcup MR; Kim JH
    Oncogene; 2016 Jun; 35(26):3410-8. PubMed ID: 26477307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of DBC1 with polyoma small T antigen promotes its degradation and negatively regulates tumorigenesis.
    Sarwar Z; Nabi N; Bhat SA; Gillani SQ; Reshi I; Un Nisa M; Adelmant G; A Marto J; Andrabi S
    J Biol Chem; 2022 Feb; 298(2):101496. PubMed ID: 34921839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
    Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
    J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein.
    Kim JE; Sung S
    Neoplasma; 2010; 57(4):365-8. PubMed ID: 20429629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
    Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DBC1/CCAR2 and CCAR1 Are Largely Disordered Proteins that Have Evolved from One Common Ancestor.
    Brunquell J; Yuan J; Erwin A; Westerheide SD; Xue B
    Biomed Res Int; 2014; 2014():418458. PubMed ID: 25610865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omic data integration links deleted in breast cancer 1 (DBC1) degradation to chromatin remodeling in inflammatory response.
    Nakayasu ES; Brown RN; Ansong C; Sydor MA; Imtiaz S; Mihai C; Sontag R; Hixson KK; Monroe ME; Sobreira TJ; Orr G; Petyuk VA; Yang F; Smith RD; Adkins JN
    Mol Cell Proteomics; 2013 Aug; 12(8):2136-47. PubMed ID: 23639857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dephosphorylation of DBC1 by Protein Phosphatase 4 Is Important for p53-Mediated Cellular Functions.
    Lee J; Adelmant G; Marto JA; Lee DH
    Mol Cells; 2015 Aug; 38(8):697-704. PubMed ID: 26194823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
    Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
    Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of DBC1 (CCAR2) affects TNFα-induced lipolysis and
    Able AA; Richard AJ; Stephens JM
    J Mol Endocrinol; 2018 Oct; 61(4):195-205. PubMed ID: 30139876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.
    Kim W; Kim JE
    Cancer Lett; 2013 Jun; 333(2):180-6. PubMed ID: 23352644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of DBC1 as a transcriptional repressor for BRCA1.
    Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
    Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.